Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+164.5%
5Y CAGR+53.8%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+164.5%/yr
vs -0.3%/yr prior
5Y CAGR
+53.8%/yr
Recent acceleration
Acceleration
+164.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$654.31M+107.5%
2024$315.34M+246.0%
2023$91.13M+157.6%
2022$35.38M-59.8%
2021$88.00M+15.6%
2020$76.09M+2196.3%
2019$-3.63M-110.1%
2018$35.88M+37.2%
2017$26.15M-49.7%
2016$52.01M-